Smartphones can accurately assess neuromuscular diseases, using video and free apps that provide faster and easier way to detect diseases earlier.
Columnist Betty Vertin shares how she explained Duchenne muscular dystrophy to her sons, who received their DMD diagnosis at a young age.
Learn more about whether ACADIA Pharmaceuticals Inc. or BioMarin Pharmaceutical Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback